181 related articles for article (PubMed ID: 30806032)
21. Over-regulation of microRNA-133b inhibits cell proliferation of cisplatin-induced non-small cell lung cancer cells through PI3K/Akt and JAK2/STAT3 signaling pathway by targeting EGFR.
Li B; Ding CM; Li YX; Peng JC; Geng N; Qin WW
Oncol Rep; 2018 Mar; 39(3):1227-1234. PubMed ID: 29344640
[TBL] [Abstract][Full Text] [Related]
22. Glibenclamide Targets Sulfonylurea Receptor 1 to Inhibit p70S6K Activity and Upregulate KLF4 Expression to Suppress Non-Small Cell Lung Carcinoma.
Xu K; Sun G; Li M; Chen H; Zhang Z; Qian X; Li P; Xu L; Huang W; Wang X
Mol Cancer Ther; 2019 Nov; 18(11):2085-2096. PubMed ID: 31341030
[TBL] [Abstract][Full Text] [Related]
23. Identification of target gene and prognostic evaluation for lung adenocarcinoma using gene expression meta-analysis, network analysis and neural network algorithms.
Selvaraj G; Kaliamurthi S; Kaushik AC; Khan A; Wei YK; Cho WC; Gu K; Wei DQ
J Biomed Inform; 2018 Oct; 86():120-134. PubMed ID: 30195659
[TBL] [Abstract][Full Text] [Related]
24. Oncogenic KRAS-induced interleukin-8 overexpression promotes cell growth and migration and contributes to aggressive phenotypes of non-small cell lung cancer.
Sunaga N; Imai H; Shimizu K; Shames DS; Kakegawa S; Girard L; Sato M; Kaira K; Ishizuka T; Gazdar AF; Minna JD; Mori M
Int J Cancer; 2012 Apr; 130(8):1733-44. PubMed ID: 21544811
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of EZH2 via activation of SAPK/JNK and reduction of p65 and DNMT1 as a novel mechanism in inhibition of human lung cancer cells by polyphyllin I.
Li L; Wu J; Zheng F; Tang Q; Wu W; Hann SS
J Exp Clin Cancer Res; 2016 Jul; 35(1):112. PubMed ID: 27421653
[TBL] [Abstract][Full Text] [Related]
26. RNA-sequencing in non-small cell lung cancer shows gene downregulation of therapeutic targets in tumor tissue compared to non-malignant lung tissue.
Reynders K; Wauters E; Moisse M; Decaluwé H; De Leyn P; Peeters S; Lambrecht M; Nackaerts K; Dooms C; Janssens W; Vansteenkiste J; Lambrechts D; De Ruysscher D
Radiat Oncol; 2018 Jul; 13(1):131. PubMed ID: 30016964
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.
Liu J; Lu KH; Liu ZL; Sun M; De W; Wang ZX
BMC Cancer; 2012 Nov; 12():519. PubMed ID: 23151088
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA expression and clinical outcome of small cell lung cancer.
Lee JH; Voortman J; Dingemans AM; Voeller DM; Pham T; Wang Y; Giaccone G
PLoS One; 2011; 6(6):e21300. PubMed ID: 21731696
[TBL] [Abstract][Full Text] [Related]
29. Hsa-miR-4271 downregulates the expression of constitutive androstane receptor and enhances in vivo the sensitivity of non-small cell lung cancer to gefitinib.
Wang C; Ding S; Sun B; Shen L; Xiao L; Han Z; Huang H
Pharmacol Res; 2020 Nov; 161():105110. PubMed ID: 32755614
[TBL] [Abstract][Full Text] [Related]
30. Targeting Adenine Nucleotide Translocase-2 (ANT2) to Overcome Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Non-Small Cell Lung Cancer.
Jang JY; Kim YG; Nam SJ; Keam B; Kim TM; Jeon YK; Kim CW
Mol Cancer Ther; 2016 Jun; 15(6):1387-96. PubMed ID: 26883272
[TBL] [Abstract][Full Text] [Related]
31. Thevebioside, the active ingredient of traditional Chinese medicine, promotes ubiquitin-mediated SRC-3 degradation to induce NSCLC cells apoptosis.
Yao C; Su L; Zhang F; Zhu X; Zhu Y; Wei L; Jiao X; Hou Y; Chen X; Wang W; Wang J; Zhu X; Zou C; Zhu S; Xu Z
Cancer Lett; 2020 Nov; 493():167-177. PubMed ID: 32829007
[TBL] [Abstract][Full Text] [Related]
32. Identification of a potential tumor suppressor gene,
Zhao X; Yongchun Z; Qian H; Sanhui G; Jie L; Hong Y; Yanfei Z; Guizhen W; Yunchao H; Guangbiao Z
Cancer Biol Med; 2020 Feb; 17(1):76-87. PubMed ID: 32296577
[No Abstract] [Full Text] [Related]
33. Regulation of Sox2 and stemness by nicotine and electronic-cigarettes in non-small cell lung cancer.
Schaal CM; Bora-Singhal N; Kumar DM; Chellappan SP
Mol Cancer; 2018 Oct; 17(1):149. PubMed ID: 30322398
[TBL] [Abstract][Full Text] [Related]
34. RUMI is a novel negative prognostic marker and therapeutic target in non-small-cell lung cancer.
Chammaa M; Malysa A; Redondo C; Jang H; Chen W; Bepler G; Fernandez-Valdivia R
J Cell Physiol; 2018 Dec; 233(12):9548-9562. PubMed ID: 29953591
[TBL] [Abstract][Full Text] [Related]
35. miR-219a-5p enhances the radiosensitivity of non-small cell lung cancer cells through targeting CD164.
Wei T; Cheng S; Fu XN; Feng LJ
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32364222
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of miR-25 modulates non-small cell lung cancer cells by targeting CDC42.
Yang T; Chen T; Li Y; Gao L; Zhang S; Wang T; Chen M
Tumour Biol; 2015 Mar; 36(3):1903-11. PubMed ID: 25432132
[TBL] [Abstract][Full Text] [Related]
37. RALY may cause an aggressive biological behavior and a dismal prognosis in non-small-cell lung cancer.
Song G; Guo G; Du T; Li X; Wang J; Yan Y; Zhao Y
Exp Cell Res; 2020 Apr; 389(2):111884. PubMed ID: 32014444
[TBL] [Abstract][Full Text] [Related]
38. Hiltonol Cocktail Kills Lung Cancer Cells by Activating Cancer-Suppressors, PKR/OAS, and Restraining the Tumor Microenvironment.
Chang SC; Zhang BX; Su EC; Wu WC; Hsieh TH; Salazar AM; Lin YK; Ding JL
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562773
[TBL] [Abstract][Full Text] [Related]
39. ID1 overexpression increases gefitinib sensitivity in non-small cell lung cancer by activating RIP3/MLKL-dependent necroptosis.
Tan HY; Wang N; Chan YT; Zhang C; Guo W; Chen F; Zhong Z; Li S; Feng Y
Cancer Lett; 2020 Apr; 475():109-118. PubMed ID: 32004572
[TBL] [Abstract][Full Text] [Related]
40. Network-based identification of key proteins and repositioning of drugs for non-small cell lung cancer.
Adeyemo OM; Ashimiyu-Abdusalam Z; Adewunmi M; Ayano TA; Sohaib M; Abdel-Salam R
Cancer Rep (Hoboken); 2024 Apr; 7(4):e2031. PubMed ID: 38600056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
